Clinical case of hemorrhagic syndrome with recurrent upper gastrointestinal bleeding

Barlamov P.N.; Khlynova O.V.; Vasileva E.R.; Zhelobov V.G.; Tokareva I.P.

doi:https://doi.org/10.17116/dokgastro20221101154

Close metadata

OBJECTIVE

To share the experience of a difficult-to-diagnose clinical case of hemorrhagic syndrome with recurrent upper gastrointestinal bleeding (UGB) due to rodenticide poisoning.

KEY POINTS

The article presents a short review and medical history of a patient with rodenticide poisoning belonging to the group of superwarfarins. The predominant clinical feature of the disease, in this case, was recurrent UGB. The cause of hemorrhagic syndrome was diagnosed late due to difficulties in taking a medical history.

CONCLUSIONS

Differential diagnosis of the recurrent UGB should include rodenticide poisoning.

Keywords:

rodenticides

gastrointestinal hemorrhage

differential diagnosis

clinical case

Authors:

Barlamov P.N.

Perm State Medical University named after Academician E.A. Wagner

Khlynova O.V.

Vagner Perm State Medical University

Vasileva E.R.

Clinical Medical-Sanitary Unit 1

Zhelobov V.G.

Perm State Medical University named after academician E.A. Wagner

Tokareva I.P.

Perm State Medical University named after Academician E.A. Wagner

Received:

18.04.2021

Accepted:

04.12.2021

Close metadata

References:

Feinstein DL, Akpa BS, Ayee MA, Boullerne AI, Braun D, Brodsky SV, Gidalevitz D, Hauck Z, Kalinin S, Kowal K, Kuzmenko I, Lis K, Marangoni N, Martynowycz MW, Rubinstein I, van Breemen R, Ware K, Weinberg G. The emerging threat of superwarfarins: history, detection, mechanisms, and countermeasures. Annual New York Academy of Sciences. 2016;1374(1):111-122. https://doi.org/10.1111/nyas.13085
Card DJ, Francis S, Deuchande K, Harrington DJ. Superwarfarin poisoning and its management. British Medical Journal. Case Reports. 2014;2014:bcr2014206360. https://doi.org/10.1136/bcr-2014-206360
Haesloop O, Tillick A, Nichol G, Strote J. Superwarfarin ingestion treated successfully with prothrombin complex concentrate. American Journal Emergency Medicine. 2016;34(1):116.e1-116.e1162. https://doi.org/10.1016/j.ajem.2015.05.033
Park J. Can we more efficiently save patients with vitamin K-dependent coagulopathy caused by superwarfarin intoxication? Korean Journal Internal Medicine. 2014;29(4):430-433. https://doi.org/10.3904/kjim.2014.29.4.430
King N, Tran MH. Long-Acting Anticoagulant Rodenticide (Superwarfarin) Poisoning: A Review of Its Historical Development, Epidemiology, and Clinical Management. Transfusion Medicine Review. 2015;29(4):250-258. https://doi.org/10.1016/j.tmrv.2015.06.002
Barlamov PN, Vasilieva ER, Golubeva ME, Zhelobov VG, Starikova OS, Shutylev AA. Acquired inhibitory form of hemophilia. Klinicheskaya meditsina. 2018;96(4):361-364. (In Russ.). https://doi.org/10.18821/0023-2149-2018-96-4-361-364
Wu YF, Chang CS, Chung CY, Lin HY, Wang CC, Shen MC. Superwarfarin intoxication: hematuria is a major clinical manifestation. Internal Journal Hematology. 2009;90(2):170-173. https://doi.org/10.1007/s12185-009-0374-6
Anderson SL, Kattappuram RS, Marrs JC, Joseph NM. Intentional brodifacoum ingestion. American Journal of Medicine. 2017; 130(1):27-28. https://doi.org/10.1016/j.amjmed.2016.08.010
Galstyan GM. Hemostasis disorders caused by a deficiency of vitamin K-dependent blood coagulation factors — pathogenesis, methods of correction and recommendations for treatment. Hematology and Transfusiology. 2012;57(2):7-21. (In Russ.).
Vzaimodejstvie lekarstvennyh sredstv. Klinicheskaya farmakologiya: nacional’noe rukovodstvo. Pod red. Belousova Y.B., Kukesa V.G., Lepahina V.K., Petrova V.I. M.: Izdatel’stvo GEOTAR-Media; 2014. (In Russ.).

Subekti I, Pramono LA. Current diagnosis and management of Graves’ disease. Acta Medica indonesiana. 2018;50(2):177-182.

Cereijido M, Contreras RG, Flores-Benítez D, Flores-Maldonado C, Larre I, Ruiz A, Shoshani L. New diseases derived or associated with the tight junction. Archives of Medical Research. 2007;38(5):465-478. https://doi.org/10.1016/j.arcmed.2007.02.003

König J, Wells J, Cani PD, García-Ródenas CL, MacDonald T, Mercenier A, Whyte J, Troost F, Brummer RJ. Human intestinal barrier function in health and disease. Clinical and Translational Gastroenterology. 2016;7(10):e196. https://doi.org/10.1038/ctg.2016.54

Pyzik A, Grywalska E, Matyjaszek-Matuszek B, Roli´nski J. Immune disorders in Hashimoto’s thyroiditis: What do we know so far? Journal of Immunology Research. 2015;2015:979167. https://doi.org/10.1155/2015/979167

Mormile R. Celiac disease and Hashimoto’s thyroiditis: A shared plot? International Journal of Colorectal Disease. 2016;31(4):947. https://doi.org/10.1007/s00384-015-2370-z

Caio G, Riegler G, Patturelli M, Facchiano A, Magistris L, Sapone A. Pathophysiology of non-celiac gluten sensitivity: Where are we now? Minerva Gastroenterologica e Dietologica. 2017;63(1): 16-21. https://doi.org/10.23736/S1121-421X.16.02346-1

Wu M, Wu Y, Deng B, Li J, Cao H, Qu Y, Qian X, Zhong G. Isoliquiritigenin decreases the incidence of colitis-associated colorectal cancer by modulating the intestinal microbiota. Oncotarget. 2016;7(51):85318-85331. https://doi.org/10.18632/oncotarget.13347

Al-Ayadhi L, Zayed N, Bhat RS, Moubayed NMS, Al-Muammar MN, El-Ansary A. The use of biomarkers associated with leaky gut as a diagnostic tool for early intervention in autism spectrum disorder: a systematic review. Gut Pathogens. 2021;13(1):54. https://doi.org/10.1186/s13099-021-00448-y

Dumitrescu L, Marta D, Dănău A, Lefter A, Tulbă D, Cozma L, Manole E, Gherghiceanu M, Ceafalan LC, Popescu BO. Serum and Fecal Markers of Intestinal Inflammation and Intestinal Barrier Permeability Are Elevated in Parkinson’s Disease. Frontiers in Neuroscience. 2021;15:689723. https://doi.org/10.3389/fnins.2021.689723

Xu G, Strathearn L, Liu B, Bao W. Corrected prevalence of autism spectrum disorder among US children and adolescents. JAMA. 2018;319(5):505. https://doi.org/10.1001/jama.2018.0001

Baldini F, Hertel J, Sandt E, Thinnes CC, Neuberger-Castillo L, Pavelka L, Betsou F, Krüger R, Thiele I; NCER-PD Consortium. Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions. BMC Biology. 2020;18(1):62. https://doi.org/10.1186/s12915-020-00775-7

Lee HS, Lobbestael E, Vermeire S, Sabino J, Cleynen I. Inflammatory bowel disease and Parkinson’s disease: common pathophysiological links. Gut. 2021;70(2):408-417. https://doi.org/10.1136/gutjnl-2020-322429

Schwiertz A, Spiegel J, Dillmann U, Grundmann D, Bürmann J, Faßbender K, Schäfer KH, Unger MM. Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson’s disease. Parkinsonism and Related Disorders. 2018;50:104-107. https://doi.org/10.1016/j.parkreldis.2018.02.022

Mulak A, Koszewicz M, Panek-Jeziorna M, Koziorowska-Gawron E, Budrewicz S. Fecal Calprotectin as a Marker of the Gut Immune System Activation Is Elevated in Parkinson’s Disease. Frontiers in Neuroscience. 2019;13:992. https://doi.org/10.3389/fnins.2019.00992

Houser MC, Chang J, Factor SA, Molho ES, Zabetian CP, Hill-Burns EM, Payami H, Hertzberg VS, Tansey MG. Stool immune profiles evince gastrointestinal inflammation in Parkinson’s disease. Movement Disorders. 2018;33(5):793-804. https://doi.org/10.1002/mds.27326

Skardelly M, Armbruster FP, Meixensberger J, Hilbig H. Expression of Zonulin, c-kit, and Glial Fibrillary Acidic Protein in Human Gliomas. Translational Oncology. 2009;2(3):117-120. https://doi.org/10.1593/tlo.09115

Dowling P, O’Driscoll L, Meleady P, Henry M, Roy S, Ballot J, Moriarty M, Crown J, Clynes M. 2-D difference gel electrophoresis of the lung squamous cell carcinoma versus normal sera demonstrates consistent alterations in the levels of ten specific proteins. Electrophoresis. 2007;28(23):4302-4310. https://doi.org/10.1002/elps.200700246

Heo SH, Lee SJ, Ryoo HM, Park JY, Cho JY. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS. Proteomics. 2007;7(23):4292-4302. https://doi.org/10.1002/pmic.200700433

Sun ZL, Zhu Y, Wang FQ, Chen R, Peng T, Fan ZN, Xu ZK, Miao Y. Serum proteomic-based analysis of pancreatic carcinoma for the identification of potential cancer biomarkers. Biochimica et Biophysica Acta. 2007;1774(6):764-771. https://doi.org/10.1016/j.bbapap.2007.04.001

Oh MK, Park HJ, Lee JH, Bae HM, Kim IS. Single chain precursor prohaptoglobin promotes angiogenesis by upregulating expression of vascular endothelial growth factor (VEGF) and VEGF receptor2. FEBS Letters. 2015;589(9):1009-1017. https://doi.org/10.1016/j.febslet.2015.03.006

Hamrita B, Chahed K, Trimeche M, Guillier CL, Hammann P, Chaïeb A, Korbi S, Chouchane L. Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas. Clinica Chimica Acta. 2009;404(2):111-118. https://doi.org/10.1016/j.cca.2009.03.033

Russo F, Linsalata M, Clemente C, D’Attoma B, Orlando A, Campanella G, Giotta F, Riezzo G. The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study. BMC Cancer. 2013;13:56. https://doi.org/10.1186/1471-2407-13-56

Scheffler L, Crane A, Heyne H, Tönjes A, Schleinitz D, Ihling CH, Stumvoll M, Freire R, Fiorentino M, Fasano A, Kovacs P, Heiker JT. Widely Used Commercial ELISA Does Not Detect Precursor of Haptoglobin2, but Recognizes Properdin as a Potential Second Member of the Zonulin Family. Frontiers in Endocrinology. 2018;9:22. https://doi.org/10.3389/fendo.2018.00022

Ajamian M, Steer D, Rosella G, Gibson PR. Serum zonulin as a marker of intestinal mucosal barrier function: May not be what it seems. PLoS One. 2019;14(1):e0210728. https://doi.org/10.1371/journal.pone.0210728

Hałasa M, Maciejewska D, Baśkiewicz-Hałasa M, Machaliński B, Safranow K, Stachowska E. Oral Supplementation with Bovine Colostrum Decreases Intestinal Permeability and Stool Concentrations of Zonulin in Athletes. Nutrients. 2017;9(4):370. https://doi.org/10.3390/nu9040370

Jiang T, Gao X, Wu C, Tian F, Lei Q, Bi J, Xie B, Wang HY, Chen S, Wang X. Apple-Derived Pectin Modulates Gut Microbiota, Improves Gut Barrier Function, and Attenuates Metabolic Endotoxemia in Rats with Diet-Induced Obesity. Nutrients. 2016;8(3):126. https://doi.org/10.3390/nu8030126

Xiao L, Cui T, Liu S, Chen B, Wang Y, Yang T, Li T, Chen J. Vitamin A supplementation improves the intestinal mucosal barrier and facilitates the expression of tight junction proteins in rats with diarrhea. Nutrition. 2019;57:97-108. https://doi.org/10.1016/j.nut.2018.06.007

Ramezani Ahmadi A, Sadeghian M, Alipour M, Ahmadi Taheri S, Rahmani S, Abbasnezhad A. The Effects of Probiotic/Synbiotic on Serum Level of Zonulin as a Biomarker of Intestinal Permeability: A Systematic Review and Meta-Analysis. Iranian Journal of Public Health. 2020;49(7):1222-1231. https://doi.org/10.18502/ijph.v49i7.3575

Liu Z, Li C, Huang M, Tong C, Zhang X, Wang L, Peng H, Lan P, Zhang P, Huang N, Peng J, Wu X, Luo Y, Qin H, Kang L, Wang J. Positive regulatory effects of perioperative probiotic treatment on postoperative liver complications after colorectal liver metastases surgery: a double-center and double-blind randomized clinical trial. BMC Gastroenterology. 2015;15:34. https://doi.org/10.1186/s12876-015-0260-z

Liu ZH, Huang MJ, Zhang XW, Wang L, Huang NQ, Peng H, Lan P, Peng JS, Yang Z, Xia Y, Liu WJ, Yang J, Qin HL, Wang JP. The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: a double-center and double-blind randomized clinical trial. The American Journal of Clinical Nutrition. 2013;97(1):117-126. https://doi.org/10.3945/ajcn.112.040949

Horvath A, Rainer F, Bashir M, Leber B, Schmerboeck B, Klymiuk I, Groselj-Strele A, Durdevic M, Freedberg DE, Abrams JA, Fickert P, Stiegler P, Stadlbauer V. Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis. Scientific Reports. 2019;9(1):12000. https://doi.org/10.1038/s41598-019-48352-5

Pietrukaniec M, Migacz M, Żak-Gołąb A, Olszanecka-Glinianowicz M, Chudek J, Duława J, Holecki M. Zonulin Family Peptide Levels in Ascites and Serum in Patients with Liver Cirrhosis: A Preliminary Study. Disease Markers. 2019;2019:2804091. https://doi.org/10.1155/2019/2804091

Khaleghi S, Ju JM, Lamba A, Murray JA. The potential utility of tight junction regulation in celiac disease: Focus on larazotide acetate. Therapeutic Advances in Gastroenterology. 2016;9(1):37-49. https://doi.org/10.1177/1756283X15616576

Di Micco S, Musella S, Sala M, Scala MC, Andrei G, Snoeck R, Bifulco G, Campiglia P, Fasano A. Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential AntiSARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation. International Journal of Molecular Sciences. 2021; 22(17):9427. https://doi.org/10.3390/ijms22179427